The pathophysiology of bleeding disorders presenting as abnormal uterine bleeding

American Journal of Obstetrics and Gynecology

Volumn 175, Issue 3 II SUPPL., 1996, Pages 770-777

  Ewenstein, B M ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

menorrhagia; Uterine bleeding; von Willebrand disease

Indexed keywords

ALPHA 2 ANTIPLASMIN; BLOOD CLOTTING FACTOR; PLASMINOGEN ACTIVATOR INHIBITOR 1;

BLEEDING DISORDER; CONFERENCE PAPER; FEMALE; FIBRINOLYSIS; HEMOSTASIS; HUMAN; MENORRHAGIA; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME; THROMBOCYTOPENIA; UTERUS BLEEDING; VON WILLEBRAND DISEASE;

EID: 0029844193     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9378(96)80083-4     Document Type: Conference Paper

References (50)

1. SR Bayer AH DeCherney Clinical manifestation and treatment of dysfunctional uterine bleeding JAMA 269 1993 1823 1828
2. RI Handin BM Ewenstein Bleeding and thrombotic disorders 3rd ed WT Branch Jr Office practice of medicine 1994 : WB Saunders Co Orlando, Florida 599 609
3. DR Mischell Abnormal uterine bleeding W Droegemueller AL Herbst DR Mischell MA Stenchever Comprehensive gynecology 1987 : The CV Mosby Co St Louis, Missouri 954 955
4. J Hawiger Formation and regulation of platelet and fibrin hemostatic plug Hum Pathol 18 1987 111 122
5. L Hallberg A-M Högdahl L Nilsson G Rybo Menstrual blood loss - a population study: variation at different ages and attempts to define normality Acta Obstet Gynecol Scand 45 1966 320 351
6. L Weinstein Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy Am J Obstet Gynecol 142 1982 159 167
7. WE Roberts Emergent obstetric management of postpartum hemorrhage Obstet Gynecol Clin North Am 22 1995 283 302
8. JG Kelton The serological investigation of patients with autoimmune thrombocytopenia Thromb Haemost 74 1995 228 233
9. JN George SJ Shattil The clinical importance of acquired abnormalities of platelet function N Engl J Med 324 1991 27 39
10. D Ginsburg EJW Bowie Molecular genetics of von Willebrand disease Blood 79 1992 2507 2519
11. JE Sadler HR Gralnick Commentary: a new classification for von Willebrand disease Blood 84 1994 676 679
12. BM Ewenstein RI Handin von Willebrand's disease RI Handin TP Stossel SE Lux Blood: principles and practice of hematology 1995 : JB Lippincott Co Philadephia 1069 1094
13. F Rodeghiero G Castaman E Dini Epidemiological investigation of the prevalence of von Willebrand's disease Blood 69 1987 454 459
14. CF Abildgaard Z Suzuki J Harrison K Jefcoat TS Zimmerman Serial studies in von Willebrand's disease: variability versus “variants.” Blood 56 1980 712 716
15. M Blombäck P Encroth BM Landgren M Lagerström O Andersson On the intraindividual and gender variability of haemostatic components Thromb Haemost 67 1992 70 75
16. B Bennett OD Ratnoff Changes in antihemophilic factor (AHF, factor VIII) procoagulant activity and AHF-like antigen in normal pregnancy, and following exercise and pneumoencephalography J Lab Clin Med 80 1972 256 263
17. M Conti D Mari E Conti ML Muggiasca PM Mannucci Pregnancy in women with different types of von Willebrand disease Obstet Gynecol 68 1986 282 285
18. LA Greer GDO Lowe JJ Walker CD Forbes Haemorrhagic problems in obstetrics and gynaecology in patients with congenital coagulopathies Br J Obstet Gynaecol 98 1991 909 918
19. GC Christiaens JJ Sixma AA Haspels Morphology of haemostasis in menstrual endometrium Br J Obstet Gynaecol 87 1980 425 439
20. WP Wendt DG LaFond Pseudohemophilia (von Willebrand's disease) in obstetrics and gynecology Am J Obstet Gynecol 83 1960 207 213
21. IM Nilsson M Blomback von Willebrand's disease in Sweden: occurrence, pathogenesis, and treatment Thromb Diath Haemorrh 9 1963 103 118
22. AJ Quick Menstruation in hereditary bleeding disorders Obstet Gynecol 28 1966 37 48
23. IS Fraser G McCarron R Markham T Resta A Watts Measured menstrual blood loss in women with menorrhagia associated with pelvic disease or coagulation disorder Obstet Gynecol 68 1986 630 633
24. T Wahlberg M Blomback P Hall G Alexsson Application of indicators, predictors, and diagnostic indices in coagulation disorders. In: evaluation of a self-administered questionnaire with binary questions Methods Infec Med 19 1980 194 200
25. CL Ward Hemorrhaging at menarche: a case report J Fam Pract 34 1992 351 354
26. PI Wathen MC Henderson CA Witz Abnormal uterine bleeding Med Clin North Am 79 1995 329 344
27. IM Nilsson von Willebrand's disease - fifty years old Acta Med Scand 201 1977 497 508
28. MA van Eijkeren GC Christiaens PC Scholten JJ Sixma Menorrhagia: current drug treatment concepts Drugs 43 1992 201 209
29. ABM Anderson PJ Haynes J Guillebaud AC Turnbull Reduction of menstrual blood loss by prostaglandin synthesis inhibitors Lancet 1 1976 774 776
30. L Mäkäräinen O Ylikorkala Primary and myoma-associated menorrhagia: role of prostaglandins and effect of ibuprofen Br J Obstet Gynaecol 93 1986 974 978
31. O Ylikorkala F Pekonen Naproxen reduces idiopathic but not fibromyoma-induced menorrhagia Obstet Gynecol 68 1986 10 12
32. BE Reubinoff A Eldor N Laufer E Sadovsky Maternal hemorrhagic complications following prophylactic low-dose aspirin and dipyridamole therapy Gynecol Obstet Invest 33 1992 241 243
33. DL Wilansky B Greisman Early hypothyroidism in patients with menorrhagia Am J Obstet Gynecol 160 1989 673 677
34. NE Blesing H Hambley GA McDonald Acquired von Willebrand disease and hypothyroidism: report of a case presenting with menorrhagia Postgrad Med J 66 1990 474 476
35. KG Mann ME Nesheim WR Church P Haley S Krishnaswamy Surface-dependent reactions of the vitamin K - dependent enzyme complexes Blood 76 1990 1 16
36. H Roberts J Lozier New perspectives on the coagulation cascade Hosp Pract 27 1992 97 112
37. GJ Broze Jr The role of tissue factor pathway inhibitor in a revised coagulation cascade Semin Hematol 29 1992 159 169
38. SI Rapaport Regulation of the tissue factor pathway Annals NY Acad Sci 614 1991 51 62
39. A Schafer Approach to bleeding J Loscalzo A Schafer Thrombosis and hemorrhage 1994 : Blackwell Scientific Publications Cambridge, Massachusetts 407 430
40. D Green K Lechner A survey of 215 non-hemophilic patients with inhibitors to factor VIII Thromb Haemost 45 1981 200 203
41. AJ Marengo-Rowe G Murff JE Leveson J Cook Hemophilia-like disease associated with pregnancy Obstet Gynecol 40 1972 56 64
42. MA van Eijkeren GC Christiaens AA Haspels JJ Sixma Measured menstrual blood loss in women with a bleeding disorder or using oral anticoagulant therapy Am J Obstet Gynecol 162 1990 1261 1263
43. J McDonagh E Kaczmarek M Hee Lee Fibrinogen and factor XIII: biology and disorders of fibrin formation and cross-linking RI Handin TP Stossel SE Lux Blood: principles and practice of hematology 1994 : JB Lippincott Co Philadelphia 1219 1259
44. D Collen HR Lijnene M Verstraete Fibrinolytic system and its disorders RI Handin TP Stossel SE Lux Blood: principles and practice of hematology 1995 : JB Lippincott Co Philadelphia 1261 1288
45. K Kottke-Marchant Laboratory diagnosis of hemorrhagic and thrombotic disorders Hematol Oncol Clin North Am 8 1994 809 853
46. G Rybo Plasminogen activators in the endometrium Acta Obstet Gynecol Scand 45 1981 411 450
47. N Gleeson M Devitt BL Sheppard J Bonnar Endometrial fibrinolytic enzymes in women with normal menstruation and dysfunctional uterine bleeding Br J Obstet Gynaecol 100 1993 768 771
48. IM Nilsson SE Bjorkman Experiences with epsilon amino caproic acid (EACA) in the treatment of profuse menstruation Acta Med Scand 177 1965 445 457
49. IM Nilsson G Rybo Treatment of menorrhagia Am J Obstet Gynecol 110 1971 713 720
50. 2-antiplasmin Blood 59 1982 1246 1251